6127:HKEXJOINN Laboratories (China) Co., Ltd. Class H Analysis
Data as of 2026-09-10 - not real-time
HK$21.84
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
The moving-average structure behind Joinn Laboratories(China)Co.,Ltd. is bullish at HKD 21.84, with short-term averages leading the long-term ones. Across the trailing 30 sessions it lost 1.5%. Momentum indicators put RSI at 39.2 (approaching oversold) with MACD reading bearish. Price has been bracketed by support at HKD 21.68 and resistance at HKD 27.46.
Valuation screens as undervalued: a P/E of 14.2 sits below the sector average of 29.8. Consensus targets land 21.5% above where the shares trade now. The 0.61% dividend yield looks covered by current payout levels.
Risk comes out at 7 of a possible 10, a elevated reading. With 30-day volatility of 60.7%, a beta of 0.59 and a maximum drawdown of 39.9%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
The horizons line up on buy — conviction 6 out of 10.
Valuation screens as undervalued: a P/E of 14.2 sits below the sector average of 29.8. Consensus targets land 21.5% above where the shares trade now. The 0.61% dividend yield looks covered by current payout levels.
Risk comes out at 7 of a possible 10, a elevated reading. With 30-day volatility of 60.7%, a beta of 0.59 and a maximum drawdown of 39.9%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
The horizons line up on buy — conviction 6 out of 10.
Top Market Events
Find the latest Joinn Laboratories China Co.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 6/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 21.09
- MACD momentum is negative
Medium Term
1–3 yearsPositive
Model confidence: 6/10
Key Factors
- Short-term moving averages stacked above long-term ones
- P/E of 14.2 versus sector average of 29.8
- Trading above the 200-day average of 21.09
Long Term
> 3 yearsPositive
Model confidence: 6/10
Key Factors
- P/E of 14.2 versus sector average of 29.8
- Analyst targets imply +21.5% versus the current price
- Profit margin of 58.2% is healthy
Key Metrics & Analysis
Financial Health
Revenue Growth1.70%
Profit Margin58.15%
P/E Ratio14.2
ROE11.53%
ROA-0.46%
Debt/Equity0.13
P/B Ratio1.6
Op. Cash FlowHK$739.0M
Free Cash FlowHK$-2067051264
Industry P/E29.8
Technical Analysis
TrendBullish
RSI39.2
SupportHK$21.68
ResistanceHK$27.46
MA 20HK$24.37
MA 50HK$23.75
MA 200HK$21.09
MACDBearish
VolumeDecreasing
Fear & Greed Index92.02
Valuation
Fair ValueHK$12.53
Target PriceHK$26.55
Upside/Downside21.55%
GradeUndervalued
TypeBlend
Dividend Yield0.61%
Risk Assessment
Beta0.59
Volatility60.71%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.